Korean Market
MATR
Aprogen Biologics
★★★

Aprogen Biologics Issues 50.8B KRW Convertible Bond to Affiliate AptoChrom; Conversion Would Surge Shares by 93%, Diluting Shareholder Value

 
EXCH
Aprogen Biologics
★

Aprogen Biologics: Persistent Losses, No Shareholder Returns, Potential Dilution from 130B Won Convertible Bonds, and Poor Corporate Governance

 
EXCH
Aprogen Biologics
★★★

Completion of 10 Billion Won Convertible Bond Issuance to Major Shareholder at Premium, but Cumulative Dilution of 169% Raises Concerns for Shareholder Value

 
MATR
Aprogen Biologics
★★★★

Issuance of 50.8 Billion Won Convertible Bonds to Repay Affiliate Debt... Dilution Risk Soars as Conversion Price Can Be Adjusted Downward

 
OWNR
Aprogen Biologics
★

Lee Young-chul acquires 7.7M convertible bonds of Aprogen Biologics, securing 34.83% stake

 
OWNR
Aprogen Biologics
★

Aprogen Biologics' largest shareholder Aprogen reports major contract shares ratio change from 13.17% to 34.05%

 
MATR
Aprogen Biologics
★★

Issuance of 10 Billion KRW 19th Convertible Bonds, Premium Conversion Price (4,433 KRW) via Third-Party Allotment to Largest Shareholder

 
EXCH
Aprogen Biologics
★

Completion of 2 Billion Won Third-Party Allotment Capital Increase (592,593 Shares)

 
EXCH
Aprogen Biologics
★★★

Major shareholder Aprogen increases stake to 58.73% via third-party allotment

 
PERI
Aprogen Biologics
★★

Aprogen Biologics Reports Q1 2026 Operating Loss of KRW 13.6B, Implements Reverse Stock Split and Rights Offering

 
OWNR
Aprogen Biologics
★

Submission of Report on Ownership of Specific Securities by Executives and Major Shareholders

 
OWNR
Aprogen Biologics
★★

Large Shareholding Report Filed for Management Influence - Stake Change Due to Capital Reduction

 
OWNR
Aprogen Biologics
★

Submission of Report on Ownership of Specific Securities by Executives and Major Shareholders

 
OWNR
Aprogen Biologics
★

Executives/Major Shareholders Securities Ownership Report Filed (No Changes)

 
OWNR
Aprogen Biologics
★

Executive/Major Shareholder Specific Securities Ownership Report Filed